These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

40 related items for PubMed ID: 24196014

  • 1. Obesity occurring in apolipoprotein E-knockout mice has mild effects on fertility.
    Zhang T, Dai P, Cheng D, Zhang L, Chen Z, Meng X, Zhang F, Han X, Liu J, Pan J, Yang G, Zhang C.
    Reproduction; 2014 Feb; 147(2):141-51. PubMed ID: 24196014
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 4. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 25; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 5. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
    Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, Zakin MM, Scott-Algara D.
    Arterioscler Thromb Vasc Biol; 2004 Apr 25; 24(4):756-61. PubMed ID: 14751811
    [Abstract] [Full Text] [Related]

  • 6. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A.
    Arterioscler Thromb Vasc Biol; 2014 Mar 25; 34(3):516-25. PubMed ID: 24436372
    [Abstract] [Full Text] [Related]

  • 7. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec 25; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 8. Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice.
    Scott NJ, Cameron VA, Raudsepp S, Lewis LK, Simpson ER, Richards AM, Ellmers LJ.
    Am J Physiol Endocrinol Metab; 2012 Mar 01; 302(5):E576-84. PubMed ID: 22185842
    [Abstract] [Full Text] [Related]

  • 9. Effects of β₃-adrenoceptor on scavenger receptor class B type 1 and its signal transduction pathway in apolipoprotein E knockout mice.
    Guo YQ, Li YF, Wang ZH.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):295-302. PubMed ID: 23911886
    [Abstract] [Full Text] [Related]

  • 10. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.
    Hirasawa H, Tanaka S, Sakai A, Tsutsui M, Shimokawa H, Miyata H, Moriwaki S, Niida S, Ito M, Nakamura T.
    J Bone Miner Res; 2007 Jul 15; 22(7):1020-30. PubMed ID: 17388726
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    Lloyd DJ, McCormick J, Helmering J, Kim KW, Wang M, Fordstrom P, Kaufman SA, Lindberg RA, Véniant MM.
    Am J Physiol Endocrinol Metab; 2008 Mar 15; 294(3):E496-505. PubMed ID: 18160459
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D, Enomoto S, Hirata Y, Nagai R, Sata M.
    Biomed Pharmacother; 2010 Dec 15; 64(10):712-7. PubMed ID: 20970951
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance.
    Gao J, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Kanzaki M, Yamamoto TT, Ishibashi S, Oka Y.
    Diabetes; 2007 Jan 15; 56(1):24-33. PubMed ID: 17192461
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC, Simari RD, Conover CA.
    Circ Res; 2007 Jun 22; 100(12):1696-702. PubMed ID: 17510462
    [Abstract] [Full Text] [Related]

  • 19. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 20. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, Nair J.
    Mutat Res; 2007 Aug 01; 621(1-2):87-94. PubMed ID: 17418875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.